洞察
Insights From Our Experts
Articles
AI, Digital Therapeutics Transformation & Cross-Industry Collaboration – What’s On Tap at Frontiers Health
Frontiers Health global conference is just a few weeks away, and as founder and chairman of the event, it’s a special few days. Every year, Frontiers Health explores the most relevant health topics, leading the way…
Assessing and Prioritizing M&A/Licensing Deals
Authors: Amardeep Udeshi, SVP, EVERSANA APAC; Ankit Kulshrestha, Senior Principal, EVERSANA APAC; Nishit Patadia, Engagement Manager, EVERSANA APAC Are you curious about the latest trends and strategies in the dynamic world of pharmaceutical mergers and acquisitions?…
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy
In the world of pharmaceuticals, pricing strategy becomes especially critical after the loss of exclusivity (LOE) for blockbuster drugs. Once patent protection ends, competition from generics or biosimilars floods the market, leading to significant price erosion.…
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted by
Anne Marie Robertson , Barry Vucsko , Gurdip Daffu, PhD , Vanith Sankaran, PhD on 9月 27, 20249/27/24
Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs. With the theme “Shaping the Future…
Digital Therapeutics: A Necessity for Italy – Insights from Roberto Ascione and Alberta Spreafico
A Collaborative Approach to Integrating Digital Therapeutics (DTx) into the Italian Health System Roberto Ascione, our President, Health Innovation, and Alberta Spreafico, PhD, MBA, Senior Vice President, Health Innovation, have co-authored the Italian publication “Digital Therapeutics:…
Enhancing Patient Adherence and Sales Outcomes in Advanced Prostate Cancer Treatment Through Proactive Push Alerts
Data and analytics play a crucial role in developing patient adherence programs by providing actionable insights and enabling data-driven decision-making. Through our latest case study, see how this information was used to develop tailored push alerts…
The Evolving Landscape of HCP Engagement and the Role of Medical Information in This Era of Digital Innovation
This poster delves into the dynamic landscape of HCP engagement and the pivotal role of Medical Information (MI). It underscores the significance of effective HCP engagement for enhancing clinical decision-making and patient outcomes and emphasizes the…
Launching in the EU/U.K.: The 7-Step Countdown to Success
THE LAUNCH Eager to explore the vast potential of launching your product in the EU/UK? While the mission is challenging, thorough preparations can ensure a smooth route to success. You only get one chance to launch,…
RWEsearch 2024 | Innovating Clinical Trial Design with Real World Evidence
At the RWEsearch Annual Summit 2024, hosted by Healthark Insights, Chris Cameron, Chief Scientific Officer at EVERSANA, emphasized that advancements in Real World Evidence will accelerate with ongoing learning and use of technology and AI.
Enhancing Quality of Life in Advanced Breast Cancer: The Role of Palbociclib
Advanced breast cancer often comes with significant physical symptoms, such as pain and fatigue, as well as side effects from treatments. The diagnosis and treatment of advanced breast cancer can lead to anxiety, depression and stress.…